GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)

BOM:500660 Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, BOM:500660 stock has a consensus rating of "Buy" and an average price target of ₹3,081. The average 1-year stock price forecast is 7.11% higher than the current stock price, while the lowest is ₹2,870 (-0.23%) and the highest is ₹3,500 (+21.68%).

Price Target: ₹3,081 (+7.11%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	₹2,870	₹3,081	₹2,977	₹3,500
Change	-0.23%	+7.11%	+3.49%	+21.68%

Analyst Ratings

The average analyst rating for BOM:500660 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Financial Forecast

Revenue This Year

42.57B

Increased by 11.39%

from 38.22B

Revenue Next Year

47.24B

Increased by 10.98%

from 42.57B

EPS This Year

68.78

Increased by 14.42%

from 60.11

EPS Next Year

79.18

Increased by 15.12%

from 68.78

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	32.78B	32.52B	34.54B	37.49B	38.22B	42.57B
Revenue Growth	12.05%	-0.80%	6.21%	8.56%	1.93%	11.39%
Gross Profit	19.00B	19.48B	20.99B	23.35B	24.46B	27.67B
Gross Margin	57.96%	59.89%	60.76%	62.29%	64.00%	65.00%
Operating Income	6.99B	7.48B	8.39B	11.14B	12.48B	14.70B
Net Income	16.95B	6.11B	5.90B	9.28B	10.36B	11.65B
EPS	-	-	-	-	60.11	68.78
EPS Growth	-	-	-	-	10.25%	14.42%
Forward PE	42.30	35.58	44.16	49.88	34.16	41.82
Dividend / Share	30.00	32.00	32.00	42.00	57.00	29.50
Dividend Growth	-	6.67%	-	31.25%	35.71%	-48.25%
Free Cash Flow	-	-	-	-	8.48B	12.00B
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Chart

Revenue	2027	2028
High	43.7B
Avg	42.6B
Low	42.1B

Revenue Growth

Chart

Revenue Growth	2027	2028
High	14.3%
Avg	11.4%
Low	10.2%

EPS Forecast

Chart

EPS	2027	2028
High	70.40
Avg	68.78
Low	67.10

EPS Growth

Chart

EPS Growth	2027	2028
High	17.1%
Avg	14.4%
Low	11.6%

Data Source: S&P Global Market Intelligence

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Price targets and consensus ratings update every hour to every three days.

Data Sources Report a data error